menu ☰
menu ˟

Lung disease greatly increases costs for patients with scleroderma

07 Dec 2017
Aryeh FischerFor patients with systemic sclerosis, interstitial lung disease and pulmonary arterial hypertension can result in significant increases in health care costs, according to research published in the Journal of Rheumatology.Aryeh Fischer, M...

Click here to view the full article which appeared in Rheumatology

Please note

The news articles accessible on the Health Well website have been compiled from various sources that are not controlled by the Institute of Public Health in Ireland (IPH). IPH is therefore not responsible for the content of external websites and the inclusion of a link to an external website from the Health Well should not be understood to be an endorsement of that website.